|
This Optic Nerve Hypoplasia web portal has been generously supported by The Karl Kirchgessner Foundation.
|
 |
Mark S. Borchert, MD, is director of the Eye Birth Defects Institute and Eye Technology Institute in The Vision Center at Children's Hospital Los Angeles, where he is head of its Division of Ophthalmology. Dr. Borchert is associate professor of clinical ophthalmology and neurology at the Keck School of Medicine of the University of Southern California. After receiving his medical degree at Baylor College of Medicine, he completed his residency at the Doheny Eye Institute of the University of Southern California and a fellowship in neuro-ophthalmology at the Massachusetts Eye & Ear Infirmary, Harvard University.
Dr. Borchert, who has been listed in “Best Doctors in America,” also has received honors from the Pan American Association of Opthalmology, the American Academy of Ophthalmology, and Society of Heed Fellows, as well as several teaching awards from the Keck School of Medicine. He directs the world’s largest study into optic nerve hypoplasia, now the single leading cause of blindness in infants in the United States and Europe.
Cassandra A. Fink, MPH, CCRP, brings her expertise in public health and clinical research practice to advancing the research agenda of The Vision Center at Children's Hospital Los Angeles. In particular, Ms. Fink manages the daily implementation of the optic nerve hypoplasia (ONH) research program, working with principal investigator Mark S. Borchert, MD. She also handles regulatory compliance for several research protocols approved by the Institutional Review Board, as well as designs and implements new and existing research projects. Her responsibilities include patient and family study enrollment, education and counseling. Ms. Fink received her bachelor of arts in psychology from the University of California, Los Angeles, and her masters of public health from Columbia University in New York.
Pamela Garcia-Filion, PhD, MPH, is a research associate with The Vision Center at Children's Hospital Los Angeles. She is responsible for providing scientific support for epidemiological and clinical research projects within the ONH research program. Dr. Garcia-Filion’s expertise is in database infrastructure and the application of research and statistical methodology to advance research objectives. Her research interest is investigating the prenatal correlates of ONH, and identifying early clinical risk factors for adverse developmental outcomes in children with ONH. Dr. Garcia-Filion completed a doctoral degree in epidemiology from the Division of Biostatistics, Department of Preventive Medicine, Keck School of Medicine, University of Southern California.
Joyce Sutedja, B.S. is the clinical research coordinator for two large studies on ONH: the ONH Registry and the Identification and Treatment of Sleep Dysfunction in Children with ONH. She is responsible for study recruitment and collecting data annually from the hundreds of study participants in these two studies. Ms. Sutedja also provides patient education on the ONH diagnosis and assistance in obtaining therapeutic interventions for ONH families. Ms. Sutedja received a bachelor of arts in English and a bachelor of science in the music industry from the University of Southern California.
|